PRINTER'S NO. 2229
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE BILL
No.
1546
Session of
2015
INTRODUCED BY CRUZ, YOUNGBLOOD, DiGIROLAMO, KINSEY, V. BROWN,
ROZZI, MURT, THOMAS, McNEILL, VEREB, MILLARD, D. COSTA,
DRISCOLL, DONATUCCI, WATSON, EVERETT, BIZZARRO, GROVE,
SCHWEYER, MAHONEY, COHEN AND FARINA, SEPTEMBER 29, 2015
REFERRED TO COMMITTEE ON HEALTH, SEPTEMBER 29, 2015
AN ACT
Amending the act of September 9, 1965 (P.L.497, No.251),
entitled, as amended, "An act requiring physicians, hospitals
and other institutions to administer or cause to be
administered tests for genetic diseases upon infants in
certain cases," further providing for newborn child screening
and follow-up program.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. Section 3(a)(1) of the act of September 9, 1965
(P.L.497, No.251), known as the Newborn Child Testing Act,
amended October 15, 2014 (P.L.2516, No.148), is amended to read:
Section 3. Newborn Child Screening and Follow-up Program.--
(a) In order to assist health care providers to determine
whether treatment or other services are necessary to avert
mental retardation, permanent disabilities or death, the
department, with the approval of the Newborn Screening and
Follow-up Technical Advisory Committee, shall establish a
program providing for:
(1) The screening tests of newborn children for the
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
following diseases:
(i) Phenylketonuria (PKU).
(ii) Maple syrup urine disease (MSUD).
(iii) Sickle-cell disease (hemoglobinopathies).
(iv) Galactosemia.
(v) Congenital adrenal hyperplasia (CAH).
(vi) Primary congenital hypothyroidism.
(vii) Certain Lysosomal storage disorders (LSDs), including:
(A) Globoid Cell Leukodystrophy (Krabbe).
(B) Fabry.
(C) Pompe.
(D) Niemann-Pick.
(E) Gaucher.
(F) Hurler Syndrome (MPS I).
(viii) Severe combined immunodeficiency disease (SCID).
* * *
Section 2. This act shall take effect in 60 days.
20150HB1546PN2229 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17